ctDNA Test is Predictive of Adjuvant Atezolizumab Benefit in MIBC
Written by
Cancer Network
Published
0
comments
0
min
Patients with muscle-invasive bladder cancer with a positive Signatera test displayed a significant improvement in disease-free and overall survival.